UTAMAMALAYSIADUNIAPOLITIKVIDEOHIBURANSUKANGAYA HIDUPBISNESENGLISHPODCASTFOTORANCANGANTEKNOLOGI

Carian mengenai topik AZD7442

Dapatkan berita terkini mengenai AZD7442 dari Astro Awani

AstraZeneca COVID-19 antibody drug offers 83% protection over six months

AstraZeneca COVID-19 antibody drug offers 83% protection over six months

These new data add to the growing body of evidence supporting AZD7442's potential to make a significant difference in the prevention and treatment of COVID-19
Thu Nov 18 2021
Ubat antibodi AstraZeneca terbukti berjaya dalam rawatan COVID-19

Ubat antibodi AstraZeneca terbukti berjaya dalam rawatan COVID-19

Ubat AZD7442 itu berpotensi mengurangkan risiko jangkitan COVID-19 atau kematian sebanyak 50 peratus.
Tue Oct 12 2021
AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19

AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19

The drug reduces the risk of developing severe COVID-19 or death by 50 pct in patients who had been symptomatic for seven days or less.
Mon Oct 11 2021
COVID-19: AZ mohon kelulusan FDA untuk rawatan cegah virus

COVID-19: AZ mohon kelulusan FDA untuk rawatan cegah virus

Ini merupakan rawatan perlindungan pertama selain daripada vaksin untuk digunakan bagi melawan COVID-19.
Tue Oct 05 2021
AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine ops

AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine ops

Antibody drug AZD7442 was shown to prevent COVID-19 in a trial.
Fri Aug 20 2021
AstraZeneca says its antibody treatment failed in preventing COVID-19 in exposed patients

AstraZeneca says its antibody treatment failed in preventing COVID-19 in exposed patients

Participants in the trial were unvaccinated adults aged 18 and above with confirmed exposure to a person with COVID-19 within eight days.
Tue Jun 15 2021